Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
(Q56019530)
Watch
English
Renal cell carcinoma
scientific article published in The Lancet
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Renal cell carcinoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
author
Bernard Escudier
series ordinal
3
object named as
Bernard Escudier
0 references
author name string
Brian I Rini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
Steven C Campbell
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
Bernard Escudier
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
language of work or name
English
0 references
publication date
5 March 2009
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
volume
373
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
issue
9669
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
page(s)
1119-1132
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
cites work
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rising incidence of renal cell cancer in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rising incidence of small renal masses: a need to reassess treatment effect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vegetable and fruit consumption and risk of renal cell carcinoma: Results from the Netherlands cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
International renal-cell cancer study. II. Analgesics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The genetic basis of cancer of the kidney
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
von Hippel-Lindau disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of the von Hippel-Lindau disease tumor suppressor gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benign renal neoplasms in adults: cross-sectional imaging findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changing concepts in the management of renal oncocytoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal mass biopsy--a renaissance?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subclassification of renal cell neoplasms: an update for the practising pathologist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histopathology and molecular genetics of renal tumors toward unification of a classification system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic significance of morphologic parameters in renal cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal medullary carcinoma. The seventh sickle cell nephropathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMES
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kidney function as a predictor of noncardiovascular mortality
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Laparoscopic renal cryoablation in 32 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal cryoablation: outcome at 3 years.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ablative techniques for the management of kidney cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Solid renal tumors: an analysis of pathological features related to tumor size
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved prognostication of renal cell carcinoma using an integrated staging system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (D
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen Renal Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hormone Treatment and Sex Steroid Receptors in Metastatic Renal Cell Carcinoma: Report of a Multicentric Prospective Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reporting results of cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sunitinib in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in advanced clear-cell renal-cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations of the VHL tumour suppressor gene in renal carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Temsirolimus, an inhibitor of mammalian target of rapamycin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
mTOR and cancer: insights into a complex relationship
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960229-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy for advanced renal cell cancer
1 reference
stated in
COCI
retrieved
30 December 2023
reference URL
https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425.PUB2
Identifiers
DOI
10.1016/S0140-6736(09)60229-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
PubMed publication ID
19269025
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19269025
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19269025%20AND%20SRC:MED&resulttype=core&format=json
retrieved
23 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit